|
US6635632B1
(en)
|
1996-12-23 |
2003-10-21 |
Athena Neurosciences, Inc. |
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
US6509331B1
(en)
|
1998-06-22 |
2003-01-21 |
Elan Pharmaceuticals, Inc. |
Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
AU4710499A
(en)
*
|
1998-06-22 |
2000-01-10 |
Elan Pharmaceuticals, Inc. |
Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use ofsuch compounds
|
|
US6958330B1
(en)
|
1998-06-22 |
2005-10-25 |
Elan Pharmaceuticals, Inc. |
Polycyclic α-amino-ε-caprolactams and related compounds
|
|
JP2002518482A
(ja)
*
|
1998-06-22 |
2002-06-25 |
エラン ファーマシューティカルズ，インコーポレイテッド |
β−アミロイドペプチド放出および／またはその合成を阻害する化合物
|
|
US6774125B2
(en)
|
1998-06-22 |
2004-08-10 |
Elan Pharmaceuticals, Inc. |
Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
US6552013B1
(en)
|
1998-06-22 |
2003-04-22 |
Elan Pharmaceuticals, Inc. |
Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
AU4707999A
(en)
*
|
1998-06-22 |
2000-01-10 |
Elan Pharmaceuticals, Inc. |
Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
|
|
HRP990246A2
(en)
|
1998-08-07 |
2000-06-30 |
Du Pont Pharm Co |
Succinoylamino benzodiazepines as inhibitors of a beta protein production
|
|
NZ525513A
(en)
|
1998-08-07 |
2004-09-24 |
Pont Pharmaceuticals Du |
Succinoylamino lactams as inhibitors of Abeta protein production
|
|
US6486350B1
(en)
|
1998-09-30 |
2002-11-26 |
Elan Pharmaceuticals Inc. |
Biological reagents and methods for determining the mechanism in the generation of β-amyloid peptide
|
|
EP1313426A2
(en)
|
1998-12-24 |
2003-05-28 |
Bristol-Myers Squibb Pharma Company |
Succinoylamino benzodiazepines as inhibitors of a-beta protein production
|
|
JP2002535314A
(ja)
|
1999-01-22 |
2002-10-22 |
エラン ファーマシューティカルズ，インコーポレイテッド |
Ｖｌａ−４により媒介される白血球接着を阻害する化合物
|
|
US6960576B2
(en)
|
1999-09-13 |
2005-11-01 |
Bristol-Myers Squibb Pharma Company |
Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production
|
|
US6503902B2
(en)
|
1999-09-13 |
2003-01-07 |
Bristol-Myers Squibb Pharma Company |
Hydroxyalkanoylaminolactams and related structures as inhibitors of a β protein production
|
|
WO2001027091A1
(en)
|
1999-10-08 |
2001-04-19 |
Du Pont Pharmaceuticals Company |
AMINO LACTAM SULFONAMIDES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
|
|
EP1251837A2
(en)
|
1999-12-23 |
2002-10-30 |
Neurochem, Inc. |
Compounds and methods for modulating cerebral amyloid angiopathy
|
|
US6525044B2
(en)
|
2000-02-17 |
2003-02-25 |
Bristol-Myers Squibb Company |
Succinoylamino carbocycles and heterocycles as inhibitors of a-β protein production
|
|
BR0107532A
(pt)
|
2000-04-03 |
2004-11-03 |
Bristol Myers Squibb Pharma Co |
Composto, uso do composto, método para o tratamento de disfunções neurológicas associadas com a produção de b-amilóide, método de inibição da atividade de y-secretase e composição farmacêutica
|
|
CA2403550A1
(en)
|
2000-04-03 |
2001-10-11 |
Hong Liu |
Cyclic lactams as inhibitors of a-.beta. protein production
|
|
US6632812B2
(en)
|
2000-04-11 |
2003-10-14 |
Dupont Pharmaceuticals Company |
Substituted lactams as inhibitors of Aβ protein production
|
|
WO2001087354A2
(en)
|
2000-05-17 |
2001-11-22 |
Bristol-Myers Squibb Pharma Company |
Use of small molecule radioligands for diagnostic imaging
|
|
BR0106717A
(pt)
|
2000-06-01 |
2002-04-16 |
Bristol Myers Squibb Pharma Co |
Compostos, composição farmacêutica e usos dos compostos de lactama inovadora
|
|
US6432944B1
(en)
|
2000-07-06 |
2002-08-13 |
Bristol-Myers Squibb Company |
Benzodiazepinone β-amyloid inhibitors: arylacetamidoalanyl derivatives
|
|
ZA200304059B
(en)
*
|
2000-12-28 |
2004-07-06 |
Daiichi Seiyaku Co |
VLA-4 inhibitors.
|
|
IL156064A0
(en)
*
|
2000-12-28 |
2003-12-23 |
Daiichi Seiyaku Co |
Vla-4 inhibitors
|
|
WO2003047576A1
(en)
*
|
2001-12-04 |
2003-06-12 |
Elan Pharmaceuticals, Inc. |
Peptide isosteres containing a heterocycle useful in the treatment of alzheimer's disease
|
|
TWI281470B
(en)
|
2002-05-24 |
2007-05-21 |
Elan Pharm Inc |
Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
|
|
TW200307671A
(en)
|
2002-05-24 |
2003-12-16 |
Elan Pharm Inc |
Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
|
|
US7459476B2
(en)
|
2002-06-27 |
2008-12-02 |
Elan Pharmaceuticals, Inc. |
Methods for treating Alzheimer's disease using hydroxyethylene compounds containing a heterocyclic amide bond isostere
|
|
FR2842523A1
(fr)
*
|
2002-07-17 |
2004-01-23 |
Sanofi Synthelabo |
Derives d'acylaminothiazole, leur preparation et leur application en therapeutique
|
|
WO2005009992A1
(ja)
|
2003-07-24 |
2005-02-03 |
Daiichi Pharmaceutical Co., Ltd. |
シクロヘキサンカルボン酸類
|
|
CN101273035A
(zh)
|
2005-09-29 |
2008-09-24 |
伊兰制药公司 |
抑制由vla-4介导的白细胞粘附的氨基甲酸酯化合物
|
|
NZ567270A
(en)
|
2005-09-29 |
2011-06-30 |
Elan Pharm Inc |
Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
EA017110B1
(ru)
|
2006-02-27 |
2012-09-28 |
Элан Фамэсьютикэлс, Инк. |
ПИРИМИДИНИЛСУЛЬФОНАМИДНЫЕ СОЕДИНЕНИЯ (ВАРИАНТЫ), СПОСОБ ПОЛУЧЕНИЯ ПИРИМИДИНИЛСУЛЬФОНАМИДНЫХ СОЕДИНЕНИЙ (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ, ОПОСРЕДОВАННОГО ИНТЕГРИНОМ α4, СПОСОБ СНИЖЕНИЯ И/ИЛИ ПРЕДУПРЕЖДЕНИЯ ВОСПАЛИТЕЛЬНОГО КОМПОНЕНТА ЗАБОЛЕВАНИЯ ИЛИ АУТОИММУННОГО ОТВЕТА
|
